Evidence map›Paper›PMID 28900505›Full record

ReviewTheranostics2017

Iron Oxide Nanozyme: A Multifunctional Enzyme Mimetic for Biomedical Applications.

Lizeng Gao, Kelong Fan, Xiyun Yan

Abstract readReview
In one paragraph

Review in Theranostics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Fenton-like Reactivity on FeSmall (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  8. Review
  9. Biomimetic FeCurrent pharmaceutical biotechnology · 2026
    Article
  10. Article
  11. Review
  12. ZSM-5-Confined Fe-ONanomaterials (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Nanozymes for Treating Ocular Diseases.Advanced healthcare materials · 2025
    Review
  15. Exploring New Bioorthogonal Catalysts: Scaffold Diversity in Catalysis for Chemical Biology.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Nanozymes: a bibliometrics review.Journal of nanobiotechnology · 2024
    Review

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lizeng GaoInstitute of Translational Medicine, School of Medicine, Yangzhou University, Yangzhou 225001, China.
Kelong FanKey Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.
Xiyun YanKey Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron oxide nanoparticles have been widely used in many important fields due to their excellent nanoscale physical properties, such as magnetism/superparamagnetism. They are usually assumed to be biologically inert in biomedical applications. However, iron oxide nanoparticles were recently found to also possess intrinsic enzyme-like activities, and are now regarded as novel enzyme mimetics. A special term, "Nanozyme", has thus been coined to highlight the intrinsic enzymatic properties of such nanomaterials. Since then, iron oxide nanoparticles have been used as nanozymes to facilitate biomedical applications. In this review, we will introduce the enzymatic features of iron oxide nanozyme (IONzyme), and summarize its novel applications in biomedicine.

Indexed as

AnimalsBiomedical TechnologyEnzymesFerric CompoundsHumansKineticsNanostructuresOxidative StressEnzymesFerric Compoundsferric oxideBiomedical applications.Enzyme-like activitiesEnzyme mimeticsIron oxideNanozyme

Identifiers

PMID28900505
PMCPMC5595127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.